Blood. 15; 111: 490207 PMID:18216292
chemotherapy-associated VTE の予測スコア
●Site of cancer
Very high risk(stomach pancreas) 2 point
high risk(lung lymphoma gynecologic bladder testicular) 1 point
●Prechemotherapy plateret count 350×10^9/L or more 1 point
●Hemoglobin lever less than 100g/L ur use of red cell growth factors 1 point
●Prechemotherapy leukocyte count more than 11×10^9/L 1 point
●BMI 35kg/㎡ or more 1 point
Low risk 0
derivation cohorts 0.8% / validation cohorts 0.3%
Intermediate risk 1-2
derivation cohorts 1.8% / validation cohorts 2.0%
High risk ≧3
derivation cohorts 7.1% / validation cohorts 6.7%
観察期間中央値 73days(5-364days)